122 related articles for article (PubMed ID: 8832227)
1. Mutations of Tyr326 in the beta 2-adrenoceptor disrupt multiple receptor functions.
Gabilondo AM; Krasel C; Lohse MJ
Eur J Pharmacol; 1996 Jun; 307(2):243-50. PubMed ID: 8832227
[TBL] [Abstract][Full Text] [Related]
2. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.
Barak LS; Tiberi M; Freedman NJ; Kwatra MM; Lefkowitz RJ; Caron MG
J Biol Chem; 1994 Jan; 269(4):2790-5. PubMed ID: 7507928
[TBL] [Abstract][Full Text] [Related]
3. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
5. Role of phosphorylation in agonist-promoted beta 2-adrenergic receptor sequestration. Rescue of a sequestration-defective mutant receptor by beta ARK1.
Ferguson SS; Ménard L; Barak LS; Koch WJ; Colapietro AM; Caron MG
J Biol Chem; 1995 Oct; 270(42):24782-9. PubMed ID: 7559596
[TBL] [Abstract][Full Text] [Related]
6. The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
Green SA; Rathz DA; Schuster AJ; Liggett SB
Eur J Pharmacol; 2001 Jun; 421(3):141-7. PubMed ID: 11516429
[TBL] [Abstract][Full Text] [Related]
7. Modeling of sequestration and down regulation in cells containing beta2-adrenergic receptors.
Barak LS; Caron MG
J Recept Signal Transduct Res; 1995; 15(1-4):677-90. PubMed ID: 8903972
[TBL] [Abstract][Full Text] [Related]
8. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.
Wieland K; Zuurmond HM; Krasel C; Ijzerman AP; Lohse MJ
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9276-81. PubMed ID: 8799191
[TBL] [Abstract][Full Text] [Related]
10. Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
Suzuki T; Nguyen CT; Nantel F; Bonin H; Valiquette M; Frielle T; Bouvier M
Mol Pharmacol; 1992 Mar; 41(3):542-8. PubMed ID: 1347641
[TBL] [Abstract][Full Text] [Related]
11. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
Zhu SJ; Toews ML
Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutagenesis of the human beta3-adrenoceptor--transmembrane residues involved in ligand binding and signal transduction.
Gros J; Manning BS; Pietri-Rouxel F; Guillaume JL; Drumare MF; Strosberg AD
Eur J Biochem; 1998 Feb; 251(3):590-6. PubMed ID: 9490030
[TBL] [Abstract][Full Text] [Related]
13. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
Blin N; Nahmias C; Drumare MF; Strosberg AD
Br J Pharmacol; 1994 Jul; 112(3):911-9. PubMed ID: 7921620
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.
Valiquette M; Bonin H; Hnatowich M; Caron MG; Lefkowitz RJ; Bouvier M
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5089-93. PubMed ID: 2164220
[TBL] [Abstract][Full Text] [Related]
15. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
Kikkawa H; Isogaya M; Nagao T; Kurose H
Mol Pharmacol; 1998 Jan; 53(1):128-34. PubMed ID: 9443940
[TBL] [Abstract][Full Text] [Related]
16. Members of the G protein-coupled receptor kinase family that phosphorylate the beta2-adrenergic receptor facilitate sequestration.
Ménard L; Ferguson SS; Barak LS; Bertrand L; Premont RT; Colapietro AM; Lefkowitz RJ; Caron MG
Biochemistry; 1996 Apr; 35(13):4155-60. PubMed ID: 8672451
[TBL] [Abstract][Full Text] [Related]
17. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.
Green SA; Turki J; Innis M; Liggett SB
Biochemistry; 1994 Aug; 33(32):9414-9. PubMed ID: 7915137
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor.
Hannawacker A; Krasel C; Lohse MJ
Mol Pharmacol; 2002 Dec; 62(6):1431-7. PubMed ID: 12435811
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adenylyl cyclase activity by beta-adrenergic agonists in a desensitization-resistant mutant cell line.
Olson MF; Tsao J; Pon DJ; Schimmer BP
Mol Endocrinol; 1991 Jan; 5(1):34-41. PubMed ID: 1850109
[TBL] [Abstract][Full Text] [Related]
20. Mutation of important amino acid residue of Asp104Lys in human beta(1)-adrenergic receptor triggers functional and constitutive inactivation.
Hossain M; Ahmed M; Bhuiyan MA; Ishiguro M; Nakamura T; Ozaki M; Nagatomo T
Biol Pharm Bull; 2008 Aug; 31(8):1517-22. PubMed ID: 18670082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
